Mediscience inks R&D deal

Photonic cancer detection device developer Mediscience Technology of Cherry Hill, NJ, has entered into a research and development agreement with the Research Foundation of City University of New York (RF-CUNY).

Under terms of the agreement, RF-CUNY will modify and integrate Mediscience's CD-Ratiometer and CD-Map products to couple a microendoscope for molecular fluorescence measurements of breast ducts, the company said.

By staff writers
March 17, 2005

Related Reading

Mediscience adds clinical consultant, January 27, 2005

Copyright © 2005

Page 1 of 180
Next Page